NexLife review: plans, prices, terms and what to verify
As of November 20, 2026, NexLife charges $129 a month for compounded tirzepatide, or $115 a month on a 12-month plan paid upfront ($1,380), and $109 or $95 a month ($1,140) for semaglutide, the same price at every dose with no membership fee, according to its plan pages. Its 3- and 6-month plans cost $125 and $119 for tirzepatide and $105 and $99 for semaglutide. Price check, month to month and all-in: Collective about $85.58 and $75.58 (including its $199 yearly membership), Mondae $126 and $87, Yucca Health $89 and Eden $99 for semaglutide; Eden charges the same $129 for tirzepatide.
Released · Last reviewed · how we verify
What NexLife charges, plan by plan
| Program | Month to month | 3-month plan | 6-month plan | 12-month plan | 12-month total |
|---|---|---|---|---|---|
| Compounded tirzepatide (also the microdose plan) | $129 | $125 | $119 | $115 | $1,380 |
| Compounded semaglutide (also the microdose plan) | $109 | $105 | $99 | $95 | $1,140 |
| Sublingual tirzepatide tablets (ODT) | $229 | $219 | $205 | $199 | $2,388 |
| Sublingual semaglutide tablets (ODT) | $199 | $185 | $177 | $165 | $1,980 |
Price check, compounded tirzepatide month to month and all-in (read November 20, 2026): Collective charges $69 a month plus a $199 annual membership (about $85.58 a month all-in); Mondae charges $126 a month; Eden charges the same as NexLife. Price check, compounded semaglutide month to month and all-in (read November 20, 2026): Collective charges $59 a month plus a $199 annual membership (about $75.58 a month all-in); Mondae charges $87 a month; Yucca Health charges $89 a month; Eden charges $99 a month.
Terms, as NexLife states them
- Billing
- Month to month is billed monthly. NexLife’s FAQ (updated November 14, 2026) says 3-, 6- and 12-month plans are paid upfront, in full, at checkout; its older cancellation-policy page (2025) describes prepaid plans paid monthly. This site follows the newer FAQ and notes the conflict.
- Dose pricing
- The same price at every dose (plan pages and FAQ).
- Membership
- None; shipping is free (FAQ).
- Included
- Provider review and medical guidance from Nexlife Medical Group, a personalized GLP-1 nutrition plan, a 1:1 call with a wellness coach, 24/7 customer support and free expedited shipping (plan pages). Labs are not stated as included.
- Pharmacies
- Its FAQ and pharmacy-partners page name two state-licensed 503A pharmacies, Absolute Pharmacy (Lutz, FL) and Boudreaux’s New Drug Store (Lake Charles, LA); the two all-plans pages also list Premium Compounding (Decatur, AL). The microdose and ODT pages refer to “503A & 503B” facilities in general; this site has not verified a 503B partner.
- States
- Conflicting: its FAQ says 45 states and Washington, D.C., and not Alabama, Louisiana, Mississippi, Virginia or West Virginia; its states page says all 50 states and D.C. Confirm at intake.
- Cancellation
- Plans renew until cancelled; cancellation takes effect 30 days after NexLife receives it, so one more shipment may be charged. Unshipped months of a 3-, 6- or 12-month plan are refunded if treatment stops; shipped medication is final.
- Guarantee
- NexLife’s refund-policy page refunds program and membership fees, not medication, if a member loses less than 5% of starting weight over six months, with conditions (enrolled from January 1, 2026, 180 consecutive days, no refill gaps, weight logged every two weeks, starting BMI 30 or more, claim between day 181 and day 210).
- Price match
- New since October: for new members switching from a licensed U.S. telehealth provider with an active compounded prescription, NexLife says it matches that provider’s regular all-in month-to-month price; intro offers, coupons and prepaid rates are excluded (full terms on its switch page).
- Medical director
- Adam Kennah, MD (NPI 1144260043; NPI registry shows an active record with emergency medicine as primary taxonomy).
How NexLife scores
On this site’s computed price-and-transparency score NexLife has 33.6 of 40, position 4 of 27 compounded programs: it passes all five transparency checks, and its month-to-month prices earn 13.6 of 20 annual-cost points. It is also this site’s featured pick, which is an editorial selection, not a computed rank.
| Check | Tirzepatide | Semaglutide |
|---|---|---|
| prints a month-to-month price | yes (+4) | yes (+4) |
| medication and care in one price | yes (+4) | yes (+4) |
| same price at every dose | yes (+4) | yes (+4) |
| no membership fee | yes (+4) | yes (+4) |
| price read on its own page on November 20, 2026 | yes (+4) | yes (+4) |
| Year at the month-to-month price | $1,548 | $1,308 |
| Total annual cost points | 13.3 of 20 | 13.9 of 20 |
| Score for this drug | 33.3 of 40 | 33.9 of 40 |
FDA warning letter
FDA’s warning-letter index lists warning letter 730096 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to NexLife; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding. FDA’s letter says website representations about compounded semaglutide and tirzepatide were false or misleading and that pictured labels showed “Nexlife” as if it were the compounder. NexLife says it responded, most recently on September 21, 2026, and that as of November 12, 2026 FDA had not published a close-out letter.
Pros and cons
Pros
- One price at every dose, no membership fee.
- Plan prices and 12-month totals printed on its own pages.
- Named 503A pharmacies.
- Written price-match terms for people switching programs.
Cons
- Collective and Mondae charge less month to month for both drugs, and Yucca Health and Eden less for semaglutide.
- Its own pages conflict on states served, pharmacy list and billing of longer plans.
- FDA warning letter 730096 (June 8, 2026), no close-out letter listed.
- Compounded medication is not FDA-approved.
Frequently asked
What does NexLife charge for compounded tirzepatide and semaglutide?
As of November 20, 2026, NexLife charges $129 a month for compounded tirzepatide, or $115 a month on a 12-month plan paid upfront ($1,380), and $109 or $95 a month ($1,140) for semaglutide, the same price at every dose with no membership fee, according to its plan pages. Its 3- and 6-month plans cost $125 and $119 for tirzepatide and $105 and $99 for semaglutide. Price check, month to month and all-in: Collective about $85.58 and $75.58 (including its $199 yearly membership), Mondae $126 and $87, Yucca Health $89 and Eden $99 for semaglutide; Eden charges the same $129 for tirzepatide.
Does NexLife charge a membership fee?
No. NexLife’s FAQ says there is no membership fee and shipping is free; its plan pages say “No memberships or contracts” and that the price is the same at every dose. Tirzepatide is $129 a month month to month and semaglutide $109 (read November 20, 2026).
Which pharmacies fill NexLife prescriptions?
NexLife’s FAQ names two state-licensed 503A pharmacies: Absolute Pharmacy in Lutz, Florida, and Boudreaux’s New Drug Store in Lake Charles, Louisiana. Its all-plans pages also list Premium Compounding in Decatur, Alabama. Ask NexLife which pharmacy will fill your prescription.
Which states does NexLife serve?
NexLife’s pages conflict. Its FAQ, updated November 14, 2026, says it is online in 45 states and Washington, D.C., and not in Alabama, Louisiana, Mississippi, Virginia or West Virginia; its states page says all 50 states and D.C. Confirm your state at the start of the intake.
Has NexLife received an FDA warning letter?
Yes. FDA issued warning letter 730096 to Nexlife Inc. on June 8, 2026 (posted June 16), about website claims for compounded semaglutide and tirzepatide. A warning letter is not a recall or a ban. NexLife says it responded, and FDA had not published a close-out letter as of November 12, 2026.
Sources
- FDA warning letter 730096 to Nexlife Inc. dba Nexlife (dated June 8, 2026, posted June 16, 2026; read November 20, 2026)
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- Federal Register 91 FR 23431: proposed 503B bulks-list decision for semaglutide, tirzepatide and liraglutide (May 1, 2026; no final notice found as of November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- NexLife tirzepatide plans page (read November 20, 2026)
- NexLife semaglutide plans page (read November 20, 2026)
- NexLife FAQ (updated November 14, 2026; read November 20, 2026)
- NexLife refund policy page (read November 20, 2026)
- NexLife switch and price-match terms (read November 20, 2026)
- NexLife statement on the FDA warning letter (read November 20, 2026)